2. Forward Looking Statements, Reconciliation and Use
of Non-GAAP Measures to U.S. GAAP
This presentation may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When
used in this presentation, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and
variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based
upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or
that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the
forward-looking statements contained in this presentation. Numerous factors, many of which are beyond the company’s control, could cause
actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s
filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the
company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made
or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP
This presentation reflects two performance measures, operating EBITDA and adjusted earnings per share, as non-U.S. GAAP measures. The most
directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is
operating profit and for adjusted earnings per share is earnings per common share-diluted.
Use of Non-U.S. GAAP Financial Information
§ Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing
operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for other
charges and adjustments. Our management believes operating EBITDA is useful to investors because it is one of the primary measures
our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating
EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of
operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical
calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies.
Additionally, operating EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not
consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the
amount used in our debt covenants.
§ Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to
common shareholders plus preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic
common shares, diluted preferred shares, and options valued using the treasury method. We provide guidance on an adjusted earnings
per share basis and are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure because a forecast of
Other Items is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to
management and investors regarding various financial and business trends relating to our financial condition and results of
operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided
with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be
considered in isolation or as a substitute for U.S. GAAP financial information.
2
3. An Attractive Hybrid Business Model
2006 1H2007
Revenue1 (in $ millions) $6,656 $3,111
Operating EBITDA1 (in $ millions) $1,244 $674
Adjusted EPS $3.00 $1.75
Celanese
Commodity Intermediate Specialty Consumer
Oil & Gas
Chemicals Products Products Products
• Dow*
• Exxon • Dow* • Rohm & Haas* • Motorola
• Eastman*
• BP • Lyondell • ICI* • Toyota
• PPG*
• Shell • Methanex • Sherwin-Williams
• FMC* • Siemens
Balance of intermediate & specialty products
* Celanese internal peer group
3 Includes Other Operating Segment, with Revenue of $257 and $117 and Operating EBITDA of ($111) and ($29), respectively
1
4. Balanced Global and End Use Positions
Paints &
Coatings Textiles
Food and Beverage
14% 6%
5%
Automotive
Consumer
9%
and Industrial
40% 35% 25%
Adhesives
4%
Consumer /
Medical
Construction Applications
8% 11%
Chemical
Performance
Additives
Industrial Applications
6% 3%
Filter Media
Paper &
14%
Packaging
Other
9% 11%
Includes oxo alcohol and polyol derivative divestiture and APL acquisition
4 End use breakdown based on 2006 est. external sales revenue
5. Businesses integrated along the “acetyls” value
chain
Building Block Differentiated Intermediates Specialty Products
Advanced
Engineered Engineered
Formaldehyde
Plastics
Materials –
AEM
Raw
(Ticona and
Materials Acetate
Affiliates)
Anhydride and
esters
Nutrinova
Acetic Acid
Emulsions/
Emulsions
PVOH
VAM
AT Plastics
Emulsions
Acetyl Consumer and
Intermediates Industrial
Specialties - CIS
5
6. 2007 – 2010: Celanese Earnings Growth Strategy
Celanese 2010 Objective:
$300-$350 million
EBITDA Growth
Balance
Operational
Asia Business Specific Sheet
Excellence
Revitalization Innovation Organic
$300 - $350 million improvement in EBITDA profile
6
7. Balance growth objective across all business groups
Primary Growth Focus
Balance Operational EBITDA
Group Asia Revitalization Innovation Organic
Sheet Excellence Impact
Consumer and
EPS Operating EBITDA
X X X X
Industrial > $100MM
Specialties
Advanced
X X X X
Engineered > $100MM
Materials
Acetyl
X X X > $100MM
Intermediates
Celanese Incremental
X X EPS
Corporate
$300 – $350 million increased EBITDA profile plus EPS potential by 2010
7
8. Long and successful history in Asia
Joint Venture Path
Polyplastics Acetate Plastics
venture with ventures in venture with
Daicel China Mitsubishi
1964 1989 2000 2007 2008
1997 1999
Continued
Acetic Acid &
VAM Acid expansion in
Direct Path Emulsions Nanjing
Production site
production
in Singapore Acetyl
sites in
Intermediates:
Nanjing,
Anhydride &
China
VAM
AEM: GUR®
and Celstran®
Success in Asia through strategic steps
8
9. Significant presence to date in China and
the rest of Asia
Japan/Fuji City Polyplastics
Korea/Seoul (KEP)
Nantong Fibers Company
Advanced Engineered Materials
Nantong (PTM Engineering
Nanjing
Plastics)
Celanese Acetate JVs
Taiwan (Polyplastics)
Celanese Acetyls
Kunming Fibers Company Intermediates
Zhuhai Fibers Company
Nanjing Complex
Sales Offices
Malaysia/Kuantan (Polyplastics)
Singapore
9
10. Approximately 50% of earnings from the
fastest growing region by 2010
2010E Regional Split
2006 Regional Split
Europe
Europe
Revenue
Revenue Asia
Asia
30-35%
25%
Americas
Americas
Europe
Europe
Earnings
Earnings Asia
Asia
45-55%
~30%
Americas
Americas
Note: Revenue breakdown based on Celanese 2006 consolidated net sales (does not include sales from equity and cost investments).
10
11. Asia continues to increase its share of global
production capacity
Products 2000 2006 2009/2010E
Acetic Acid1 40% 52% 59%
VAM1 39% 46% 51%
Acetic Anhydride1 25% 26% 34%
VAE Emulsions2 6% 18% 26%
GUR®3 17% 19% 27%
Celstran®4 3% 6% 16%
Sources:
1 Tecnon and SRI.
2 Kline and Celanese estimates.
3 Celanese estimates for capacity information in the UHMW-PE industry.
11 4 BRG Townsend, Inc., publicly available data and Celanese estimates.
13. Nanjing: fully integrated, low cost facility
Construction
►
GUR® Celstran®
Flare
Warehouse proceeding on
Unit Unit
schedule
Vinyl Acetate
Integrated complex
►
Acetic Anhydride Unit
Monomer Unit
Leading technologies
►
Advantaged feedstock
►
Acetic
Utilities /
Acid
Tank Farm Highly capital efficient
►
Unit
Emulsions
Complex
EHS excellence
►
Administration & Integrated IP
►
Maintenance
protection
Platform for growth in Asia
13
14. Nanjing Projects: Facts and Figures
2007 2008 2009
Acetic Acid
≥ Capacity – 600 kT (expandable
to 1,200 kT)
≥ AO+™ Technology
Acetic Anhydride
≥ Capacity – 100 kT
VAM
≥ Capacity – 300 kT
≥ Vantage Plus™ Technology
Nanjing Facts
≥ Location – Nanjing City
Emulsions
Industrial Park (NCIP)
≥ Capacity – 60 kT
• Only one of two state
≥ VAE – 48 kT
approved industrial
≥ Conventional Emulsions – 12 kT
parks
• Total area of NCIP ~
Celstran®
45 kilometers
≥ Capacity – 4 kT
≥ ~ 19 hectares of land use (expandable to 8 kT)
rights acquired
GUR®
≥ Employees – 234 currently
and ~300+ expected by 2009 ≥ Capacity – 16 kT
(including shared services) (expandable to 32 kT)
14
15. Nanjing: Highly integrated complex with
leading Celanese technologies
Coal based Acetic Acid
CO (AO+™) ~40%
20%
~40% M
Acetic
e
100%
Anhydride
Methanol r
c
Vinyl Acetate
h
~90%
(VAntage Plus™)
a
n
t
~10%
S
Ethylene Emulsions a
100%
l
e
s
GUR®
100%
Polypropylene Celstran®
100%
Projected $600 - $700 million in incremental sales by 2010
15
16. Nanjing: Advantaged feedstock position with
coal-based CO
1
Coal Gasification
Low Cost
►
Significant cost advantage
> 25% advantage versus natural gas
§
(typical alternative feedstock)
Synergies from CO and methanol co-
§
production
Coal - water
slurry
Reliable
►
~50% of the 55 coal gasification units
in the world are in China
Redundant critical systems enhance
reliability
Coal gasification in China: low cost and reliable
From William Preston presentation at Gasification Technologies Council in 2001
1
16
17. Nanjing: Integrated approach to protecting our
IP in China
Design, Engineering, & Construction
Process design developed outside China
►
Critical Equipment
Selected equipment purchase outside China
► & Design
Security check on key contractor personnel
►
Hiring Policy & Practices
Criteria includes company specific background
►
Employment contracts with IP language
►
3-5 year bonding of critical employees
►
What is IP?
Operation Including Information Control
Separation of jobs, limited rotation
►
Selected critical lab analyses in Singapore
►
Biometric access to IP sensitive areas
►
Biometrics
Litigation Track Record
100% success rate
►
> $100 million recovery (5 lawsuits)
►
3 others pending litigation
►
17
19. Nanjing complex builds upon Celanese’s strong
position in China
Celanese will continue to remain competitive as the global leader in
►
Acetic Acid
Strong cost position
Global presence gives customers reliability of supply
Focus on growth in China and the rest of Asia
Ability exists to double the capacity of both Nanjing and Singapore at a
fraction of the original capital cost
► Downstream integration into VAM, Acetic Anhydride, and Esters give
Celanese a unique position to supply the global market
19
20. Leading position in the acetyl value chain
VAM
Acetic Acid
~5MM metric tons
~10MM metric tons
Others
Other Celanese Celanese
Kuraray 19%
29% 25% 26%
2%
Showa
3%
Gohsei
Daicel Nanjing
Nanjing 3%
3% 4%
6% BP
Dairen
5%
Eastman 11%
DuPont
3% BP 6% Millennium Dow
23% Sinopec
Lyondell
Sopo 6% 8%
Acetic Anhydride 7%
5%
6%
Other ~2.5MM metric tons
16%
Eastman
Jilin
31%
4%
Rhodia
5%
BP
6%
Daicel
Celanese
Nanjing
12%
22%
4%
Celanese: Integrated leader in Acetyls
Source: Tecnon 2006
20
21. Acetyl Intermediates: High utilization rates
expected through 2009; unmatched operating cost
advantage
2009E Acetic Acid Cost Curve
Acetic Acid Supply-Demand Balance based on Effective Capacity (kt)
12,000
High Cost Supply
10,000
Pampa (under
8,000
review)
Celanese
KT
6,000
technology
4,000
Conventional
MeOH /CO
AO Plus™/Leading
2,000
By-
Competition
prod
0
2004 2005 2006E 2007E 2008E 2009E 4,000 6,000 8,000 10,000
0 12,000
2,000
Capacity
Utilization1(Nov, 2006): 91% 93% 92% 91% 91% 92%
High Cost Capacity
Low Cost Capacity
Demand
1Based on effective capacity at 90% of nameplate (Celanese estimate)
Source: Celanese estimates; Available Public Data
21
24. Translating Vinyl Acetate success to Asia
Global Latex Emulsions Market1
2.4
1.8 Why China and Why Vinyls?
Demand in China growing at
►
Regional Size (B tonnes)
15%
1.3 >10%
1.4
%
22
Diverse end-market segments
►
1.2 32% 30%
CAGR
36%
Good value proposition versus
►
%
0.7 11
competitive systems
30%
27%
26% %
25
Meets low VOC requirements
►
53%
39%
40%
36%
35%
0.0
US Europe China China 2010
Vinyls 100% acrylic Styrene acrylics
1Excludes SBR, other minor latexes & powders
Sources: Kline Synthetic Latex Polymers Market Analysis Europe 2005, North America 2004 and China 2006. China 2010 data obtained from Kline and Celanese estimates.
24
25. Chinese Market offers major growth opportunities
China Emulsions Market Overview
China Production Volume
500
400
15%
(Dry Tonnes)
300
Expected Annual Growth Rate
200
15%
100 30%
15%
0
Adhesives Coatings Construction Nonwovens
Sources: Kline and SAI
25
27. Focus on High Performance
Polymers and Thermoplastics
Global High Performance Polymer and Engineering Thermoplastics
2006E: ~8 MM tons (2006E Growth = 6 %)
€ 100 / kg
High Performance Polymers (HPP)
€ 10 / kg 4 %1 Engineering Thermoplastics (ETP)
€ 3 / kg
Performance
others = 3 %
Standard Polymers
96 %
PU = 6 %
PET = 5 %
ABS, SAN, ASA: 4 %
€ 1 / kg
PS, EPS = 9 %
PVC = 17 %
PE = 34 % PP = 19 %
Range of Products
1Comprising:PEEK (the top end of HPP and ETP pyramid), PA 6 & PA 66, PA 11 and PA 12, PC, POM, PBT, COPE, PET technical, PPE, COC & COP, UHMW-PE,
PPS, LCP, High Performance Nylons, PEI, PES & PSU, PTFE & other fluoropolymers
27
28. Strong product portfolio
Electrical Consumer
#1 or
Product Transportation & & Industrial Medical
#2 Electronics Appliance
Fortron® X X X
(Polyphenylensulfide)
GUR®
X X X X
(Ultra-high molecular weight
PE)
Hostaform® X X X X X
(Polyacetals)
Celstran®
X X
(Long fiber reinforced
thermoplastics)
Vectra®
X X X X
(Liquid Crystal Polymer)
Celanex®
X X X X
(Polyester Engineering
Resins)
Leading position in > 80 % of sales
28
29. Continued focus on transportation penetration
in China
Global Vehicle Production 2006 - 2012 Advanced Engineered Materials Type of Resins
China
6
2001
US
Japan
12
2006E
Germ any
India
18
2010E
South Korea
2006 Production
France
40
Highest
Production Growth 2006 - 2012
Current
Canada
Brazil
China
2.5
Current
Spain
0 3,000 6,000 9,000 12,000 15,000 18,000
Pounds per Vehicle
Vehicle Production (units)
Source: Management Estimates
Source: Global Insight
29
30. Most of GUR’s Global Target Markets are
Being Commercialized in Asia
Fibers for Security
Sheet & Profile – Applications & Abrasion
Auto & Motorcycle Resistant Films
Material Handling
Batteries
Applications
Porous – Water
Filtration
30
32. Project delays continue to allow increasing
demand to absorb new supply
CE Investor Day 2005
Company Capacity Original Date CE Investor Day 2006 Updates
Comments
Fanavaran 150KT Start 2005 Rumored to have started Commercial Production in July,
commissioning 2006
Wujing 200KT Start 2005 No sign of construction Construction under way; Pending
Litigation; Startup expected Mid-
2007
SOPO 150KT Start 2005 Completed, explosion 3 Operational in 1Q 2006; expansion
days later in July, 2006
BP/FPC 300KT Early 2005 December 2005 Commercial Production in 2Q 2006
BP/Yaraco 150KT Early 2005 Operational mid-2005 Commercial Production mid-2005
Lunan 200KT June 2005 Now commercializing Commercial Production in 1Q 2006
Daqing 200KT Late 2006 NA Expected Mid- 2007; replaces high
cost capacity
BP/Sinopec 500KT Start 2008 Construction not yet Construction not yet begun;
begun Expected mid-2009
Sipchem 425KT Start 2008 Website states Q3 2008 Pending Litigation; Expected mid-
2009
Hualu Hengsheng 200KT 2009 Expected Late 2009 Expected Late 2009
32
33. Reg G: Reconciliation of Diluted Adjusted EPS
Adjusted Earnings Per Share - Reconciliation of a Non-U.S. GAAP Measure
Three Months Ended Twelve Months Ended
December 31, December 31,
2006 2005 2006 2005
(in $ millions, except per share data)
Earnings from continuing operations
before tax and minority interests 174 664
158 374
Non-GAAP Adjustments:
(1) 40
Other charges and other adjustments * (51) 50
- - - 102
Refinancing costs
Adjusted earnings from continuing operations
before tax and minority interests 173 704
107 526
(43) (186)
Income tax provision on adjusted earnings ** (5) (106)
(1) (4)
Minority interests 4 (37)
4 1
Earnings from discontinued operations, net of tax and adjustments *** (5) 1
(2) (10)
Preferred dividends (3) (10)
Adjusted net earnings available to common shareholders 131 505
98 374
2 10
Add back: Preferred dividends 3 10
Adjusted net earnings for diluted adjusted EPS 133 101 515 384
Diluted shares (millions)
158.7 158.6
Weighted average shares outstanding 158.6 158.6
12.0
12.0 12.0
Assumed conversion of Preferred Shares 12.0
1.2
1.8 0.9 0.9
Assumed conversion of stock options
172.5 171.8
Total diluted shares 171.5 171.5
Adjusted EPS from continuing operations 0.75 0.63 2.99 2.23
Earnings per common share from discontinued operations, net of
adjustments 0.02 (0.03) 0.01 0.01
Adjusted EPS 0.77 0.60 3.00 2.24
* See Slide 35 for details
** The U.S. GAAP tax rate for the three months ended December 31, 2006 is 54% and twelve months ended December 31, 2006 is 38%. The company’s adjusted
tax rate for the three months ended December 31, 2006 is 25% and the resulting full year adjusted tax rate is 26%. The difference between our US GAAP
taxes and our adjusted taxes are due to: (i) the favorable impact of purchase accounting on our net operating losses ($59 million); (ii) the elimination of
discrete tax items not related to the current period ($6 million) and (iii) the elimination of tax related to a dividend from an equity investment not
included in earnings under US GAAP ($17 million).
*** Does not include gain on sale related to discontinued operations.
33
34. Reg G: Reconciliation of Diluted Adjusted EPS
Adjusted Earnings Per Share - Reconciliation of a Non-U.S. GAAP Measure
Three Months Ended Six Months Ended
June 30, June 30,
2007 2006 2007 2006
(in $ millions, except per share data)
Earnings (loss) from continuing operations
before tax and minority interests (168) 134 3 251
Non-GAAP Adjustments:
1
Other charges and other adjustments 115 37 166 61
- -
Refinancing costs 256 254
Adjusted earnings from continuing operations
before tax and minority interests 203 171 423 312
2
Income tax provision on adjusted earnings (57) (48) (118) (87)
(1)
- -
Minority interests (1)
Adjusted earnings from continuing operations 146 122 305 224
(3) (5)
Preferred dividends (2) (5)
Adjusted net earnings available to common shareholders 143 120 300 219
3 5
Add back: Preferred dividends 2 5
Adjusted net earnings for adjusted EPS 146 122 305 224
Diluted shares (millions)
Weighted average shares outstanding 156.9 158.6 158.1 158.6
12.0
12.0
Assumed conversion of Preferred Shares 12.0 12.0
-
0.2
Assumed conversion of Restricted Stock 0.5 -
1.5 1.4
4.2
Assumed conversion of stock options 5.2
Total diluted shares 174.6 172.1 174.5 172.0
Adjusted EPS 0.84 0.71 1.75 1.30
1
See Slide 36 for details
2
The adjusted tax rate for the three and six months ended June 30, 2007 is 28% based on the original full year 2007 guidance.
34
35. Reg G: Reconciliation of Other Charges and
Other Adjustments
Other Charges: *
Three Months Ended Twelve Months Ended
December 31, December 31,
(in $ millions) 2006 2005 2006 2005
1 12
Employee termination benefits 3 19
(1)
(1)
Plant/office closures 5 20
11
Total restructuring - 8 39
-
- 25
Asset impairments
(2) (30) (5)
Insurance recoveries associated with plumbing cases (34)
(1)
- 4
Other 36 **
Total (2) (23) 10 66
Other Adjustments: ***
Three Months Ended Twelve Months Ended
December 31, December 31,
(in $ millions) 2006 2005 2006 2005
Executive severance & legal costs related
2 30
to Squeeze-Out - -
Favorable impact on non-operating foreign
- -
exchange position - (14)
- -
Advisor monitoring fee - 10
- -
Purchase accounting for inventories (4) 12
8 12
Business Optimization - -
- -
Settlement of transportation-related antitrust matters (36) (36)
- -
Gain on disposition of Acetate properties (23) (23)
- -
Loss on disposition of COC business 35 35
(11) (11)
Gain on disposal of investment (Pemeas) - -
2 (1)
Other - -
1 (28) 30 (16)
Total
(1) (51) 40 50
Total other charges and other adjustments
* Previously described as Special Charges
** Termination of advisor monitoring fee
*** These items are included in net earnings but not included in other charges.
35
36. Reg G: Reconciliation of Other Charges and
Other Adjustments
Other Charges:
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions) 2007 2006 2007 2006
Employee termination benefits 25 9 25 11
- -
-
Plant/office closures 2
Total restructuring 25 11 25 11
- -
Insurance recoveries associated with plumbing cases (2) (3)
Long-term compensation triggered by Exit Event 74 - 74 -
3 3
Asset impairments - -
Ticona Kelsterbach relocation 3 - 3 -
3
- 1
Other 4
Total 105 12 106 12
Other Adjustments: 1
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions) 2007 2006 2007 2006
Executive severance & other costs related
- 1
to Squeeze-Out 13 23
- 10
Ethylene Pipeline Exit -
3 5
Business Optimization - -
9 9
Foreign exchange loss related to refinancing transaction - -
2
Discontinued Methanol production (2) 12 31 26
- 4
Other - -
10 25 60 49
Total
115 37 166 61
Total other charges and other adjustments
1
These items are included in net earnings but not included in other charges.
2
Adjusted earnings per share included earnings from its discontinued methanol production which was included in the company's 2007 guidance.
36
37. 37
Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
a Non-U.S. GAAP Measure.
Three Months Ended Twelve Months Ended
December 31, December 31,
(in $ millions) 2006 2005 2006 2005
Net Sales
1,184 4,742
Chemical Products 1,096 4,299
224 915
Technical Polymers Ticona 213 887
186 700
Acetate Products 160 659
38 176
Performance Products 40 180
59 257
Other Activities * 69 144
(35) (134)
Intersegment eliminations (38) (136)
Total 1,656 1,540 6,656 6,033
Operating Profit (Loss)
162 637
Chemical Products 149 585
29 145
Technical Polymers Ticona (2) 60
31 106
Acetate Products 43 67
7 50
Performance Products 10 51
(44) (191)
Other Activities * (33) (190)
Total 185 167 747 573
Equity Earnings and Other Income/(Expense) **
25 72
Chemical Products 36 80
13 55
Technical Polymers Ticona 11 54
- 21
Acetate Products 2 4
2 3
Performance Products 1 (1)
14 23
Other Activities * 5 13
Total 54 55 174 150
Other Charges and Other Adjustments ***
2 12
Chemical Products (38) (15)
(1) (5)
Technical Polymers Ticona 6 31
- -
Acetate Products (24) (14)
- -
Performance Products - 1
(2) 33
Other Activities * 5 47
Total (1) (51) 40 50
Depreciation and Amortization Expense
37 155
Chemical Products 48 166
17 65
Technical Polymers Ticona 18 60
6 24
Acetate Products 8 29
4 15
Performance Products 3 13
6 8 24 17
Other Activities *
Total 70 85 283 285
Operating EBITDA
226 876
Chemical Products 195 816
58 260
Technical Polymers Ticona 33 205
Reg G: Reconciliation of Operating EBITDA
37 151
Acetate Products 29 86
13 68
Performance Products 14 64
(26) (111)
Other Activities * (15) (113)
Total 308 256 1,244 1,058
* Other Activities primarily includes corporate selling, general and administrative expenses
and the results from AT Plastics and captive insurance companies.
** Includes equity earnings from affiliates and other income/(expense), which is primarily dividends
from cost investments.
*** Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations.
38. 38
Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
a Non-U.S. GAAP Measure.
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions) 2007 2006 2007 2006
Net Sales
1,002 2,004
Chemical Products 977 1,914
257 519
Technical Polymers Ticona 230 461
235 458
Acetate Products 176 343
47 92
Performance Products 48 97
1
Other Activities 58 117
68 129
(43) (79)
Intersegment eliminations (42) (67)
Total 1,556 1,457 3,111 2,877
Operating Profit (Loss)
91 239
Chemical Products 130 251
32 68
Technical Polymers Ticona 38 79
29 58
Acetate Products 29 52
16 32
Performance Products 16 33
1
Other Activities (97) (120)
(61) (107)
Total 71 152 277 308
Equity Earnings and Other Income/(Expense) 2
18 22
Chemical Products 15 23
16 30
Technical Polymers Ticona 14 29
34 34
Acetate Products 21 21
1 1
Performance Products 1 1
1
Other Activities (2) 3
(4) (3)
Total 67 47 90 71
3
Other Charges and Other Adjustments
30 76
Chemical Products 20 33
5 5
Technical Polymers Ticona (2) (4)
8 9
Acetate Products - -
- -
Performance Products - -
1
Other Activities 72 76
19 32
Total 115 37 166 61
Depreciation and Amortization Expense
37 71
Chemical Products 42 75
17 34
Technical Polymers Ticona 16 32
9 16
Acetate Products 5 12
4 8
Performance Products 4 8
1
12
Other Activities 6 7 12
Total 73 74 141 139
Operating EBITDA
176 408
Chemical Products 207 382
Reg G: Reconciliation of Operating EBITDA
70 137
Technical Polymers Ticona 66 136
80 117
Acetate Products 55 85
21 41
Performance Products 21 42
1
Other Activities (21) (29)
(39) (66)
Total 326 310 674 579
1
Other Activities primarily includes corporate selling, general and administrative expenses
and the results from AT Plastics and captive insurance companies.
2
Includes equity earnings from affiliates, dividends from cost investments and other income/(expense)
3
Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations.
